Phase 3RecruitingINTERVENTIONAL
Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome
ClinicalTrials.gov · NCT05586802 · Registry updated: 2026-05-11
- Condition / research focus
- Klinefelter Syndrome
- Sponsor
- Georgios Papadakis
- Countries with listed sites
- Switzerland
- Registry dates and results
- Start: 2023-03-21. Completion: 2027-04-30 (may be estimated). No results posted in this registry response.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Anastrozole (drug) — also listed as: Anastrozole Teva
- Semaglutide (drug) — also listed as: Ozempic
- human chorionic gonadotropin (drug) — also listed as: Choriomon
- Testosterone gel (drug) — also listed as: Tostran
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Service of Endocrinology, Diabetes & Metabolism
Lausanne, Switzerland
Site recruitment: Recruiting